The gut microbiota: A major player in the toxicity of environmental pollutants?

npj Biofilms and Microbiomes

Volumn 2, Issue , 2016, Pages

  Claus, Sandrine P ^a   Guillou, Hervé ^b   Ellero Simatos, Sandrine ^b  

^a UNIVERSITY OF READING   (United Kingdom)

^b TOXALIM RESEARCH CENTRE IN FOOD TOXICOLOGY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85010020541     PISSN: None     EISSN: 20555008     Source Type: Journal    
DOI: 10.1038/npjbiofilms.2016.3     Document Type: Review

References (111)

1. Qin, J. et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464, 59-65 (2010).
2. Spor, A., Koren, O. & Ley, R. Unravelling the effects of the environment and host genotype on the gut microbiome. Nat. Rev. Microbiol. 9, 279-290 (2011).
3. Yatsunenko, T. et al. Human gut microbiome viewed across age and geography. Nature 486, 222-227 (2012).
4. O'Hara, A. M. & Shanahan, F. The gut flora as a forgotten organ. EMBO Rep. 7, 688-693 (2006).
5. Sousa, T. et al. The gastrointestinal microbiota as a site for the biotransformation of drugs. Int. J. Pharm. 363, 1-25 (2008).
6. Sommer, F. & Bäckhed, F. The gut microbiota-masters of host development and physiology. Nat. Rev. Microbiol. 11, 227-238 (2013).
7. Ley, R. E., Turnbaugh, P. J., Klein, S. & Gordon, J. I. Microbial ecology: human gut microbes associated with obesity. Nature 444, 1022-1023 (2006).
8. Cummings, J. H., Macfarlane, G. T. & Macfarlane, S. Intestinal bacteria and ulcerative colitis. Curr. Issues Intest. Microbiol. 4, 9-20 (2003).
9. Qin, J. et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490, 55-60 (2012).
10. Bajaj, J. S. et al. Altered profile of human gut microbiome is associated with cirrhosis and its complications. J. Hepatol. 60, 940-947 (2014).
11. Le Roy, T. et al. Intestinal microbiota determines development of non-Alcoholic fatty liver disease in mice. Gut 62, 1787-1794 (2012).
12. Darfeuille-Michaud, A. et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 127, 412-421 (2004).
13. Nakatsu, G. et al. Gut mucosal microbiome across stages of colorectal carcinogenesis. Nat. Commun. 6, 8727 (2015).
14. Ling, Z. et al. Altered fecal microbiota composition associated with food allergy in infants. Appl. Environ. Microbiol. 80, 2546-2554 (2014).
15. Casals-Casas, C. & Desvergne, B. Endocrine disruptors: from endocrine to metabolic disruption. Ann. Rev. Physiol. 73, 135-162 (2011).
16. Snedeker, S. M. & Hay, A. G. Do interactions between gut ecology and environmental chemicals contribute to obesity and diabetes? Environ. Health Perspect. 120, 332-339 (2012).
17. Scheline, R. R. Metabolism of foreign compounds by gastrointestinal microorganisms. Pharmacol. Rev. 25, 451-523 (1973).
18. Rowland, I. R. Factors affecting metabolic activity of the intestinal microflora. Drug. Metab. Rev. 19, 243-261 (1988).
19. Kang, M. J. et al. The effect of gut microbiota on drug metabolism. Expert. Opin. Drug Metab. Toxicol. 9, 1295-1308 (2013).
20. Haiser, H. J. & Turnbaugh, P. J. Developing a metagenomic view of xenobiotic metabolism. Pharmacol. Res. 69, 21-31 (2013).
21. Jeong, H. G. et al. Role of intestinal microflora in xenobiotic-induced toxicity. Mol. Nutr. Food Res. 57, 84-99 (2013).
22. Gao, J., Ellis, L. B. M. & Wackett, L. P. The University of Minnesota Biocatalysis/Biodegradation Database: improving public access. Nucleic Acids Res. 38, D488-D491 (2010).
23. Gans, J., Wolinsky, M. & Dunbar, J. Computational improvements reveal great bacterial diversity and high metal toxicity in soil. Science 309, 1387-1390 (2005).
24. Haschek, W. M., Rousseaux, C. G. & Wallig, M. A. Haschek and Rousseaux's Handbook of Toxicologic Pathology (Elsevier, 2013).
25. Rafii, F., Franklin, W. & Cerniglia, C. E. Azoreductase activity of anaerobic bacteria isolated from human intestinal microflora. Appl Environ Microbiol 56, 2146-2151 (1990).
26. Rafil, F., Franklin, W., Heflich, R. H. & Cerniglia, C. E. Reduction of nitroaromatic compounds by anaerobic bacteria isolated from the human gastrointestinal tract. Appl. Environ. Microbiol. 57, 962-968 (1991).
27. Roldán, M. D., Pérez-Reinado, E., Castillo, F. & Moreno-Vivián, C. Reduction of polynitroaromatic compounds: The bacterial nitroreductases. FEMS Microbiol. Rev. 32, 474-500 (2008).
28. Williams, J. R., Grantham, P. H., Marsh, H. H., Weisburger, J. H. & Weisburger, E. K. Participation of liver fractions and of intestinal bacteria in the metabolism of N-hydroxy-N-2-fluorenylacetamide in the rat. Biochem. Pharmacol. 19, 173-188 (1970).
29. Eriksson, H. & Gustafsson, J. A. Steroids in germfree and conventional rats. Sulpho-And glucuronohydrolase activities of caecal contents from conventional rats. Eur. J. Biochem. 13, 198-202 (1970).
30. Bakke, J., Gustafsson, J. A. Mercapturic acid pathway metabolites of xenobiotics: generation of potentially toxic metabolites during enterohepatic circulation. Trends Pharmacol. Sci. 5: 517-521 (1984).
31. Bosetti, C., Boffetta, P. & La Vecchia, C. Occupational exposures to polycyclic aromatic hydrocarbons, and respiratory and urinary tract cancers: A quantitative review to 2005. Ann. Oncol. 18, 431-446 (2007).
32. Van de Wiele, T. et al. Human colon microbiota transform polycyclic aromatic hydrocarbons to estrogenic metabolites. Environ. Health Perspect. 113, 6-10 (2005).
33. Renwick, A. G. & Drasar, B. S. Environmental carcinogens and large bowel cancer. Nature 263, 234-235 (1976).
34. Möller, L. In vivo metabolism and genotoxic effects of nitrated polycyclic aromatic hydrocarbons. Environ. Health Perspect. 102 (Suppl 4), 139-146 (1994).
35. Hirayama, K. et al. Effects of human intestinal flora on mutagenicity of and DNA adduct formation from food and environmental mutagens. Carcinogenesis 21, 2105-2111 (2000).
36. Möller, L., Corrie, M., Midtvedt, T., Rafter, J. & Gustafsson, J. A. The role of the intestinal microflora in the formation of mutagenic metabolites from the carcinogenic air pollutant 2-nitrofluorene. Carcinogenesis 9, 823-830 (1988).
37. Deeds, F. & Wilson, R. H. The carcinogenic activity of 2-Acetaminofluorene; effects of concentration and duration of exposure. Fed. Proc. 5, 173 (1946).
38. Doolittle, D. J., Sherrill, J. M. & Butterworth, B. E. Influence of intestinal bacteria, sex of the animal, and position of the nitro group on the hepatic genotoxicity of nitrotoluene isomers in vivo. Cancer Res. 43, 2836-2842 (1983).
39. Rickert, D. E., Butterworth, B. E. & Popp, J. A. Dinitrotoluene: Acute toxicity, oncogenicity, genotoxicity, and metabolism. Crit. Rev. Toxicol. 13, 217-234 (1984).
40. Rickert, D. E., Long, R. M., Krakowka, S. & Dent, J. G. Metabolism and excretion of 2, 4- [14C]Dinitrotoluene in conventional and axenic Fischer-344 rats. Toxicol. Appl. Pharmacol. 59, 574-579 (1981).
41. Guest, D., Schnell, S. R., Rickert, D. E. & Dent, J. G. Metabolism of 2, 4-dinitrotoluene by intestinal microorganisms from rat, mouse, and man. Toxicol. Appl. Pharmacol. 64, 160-168 (1982).
42. Kim, K.-S. et al. Associations of organochlorine pesticides and polychlorinated biphenyls in visceral vs. subcutaneous adipose tissue with type 2 diabetes and insulin resistance. Chemosphere 94, 151-157 (2014).
43. Mrema, E. J. et al. Persistent organochlorinated pesticides and mechanisms of their toxicity. Toxicology 307, 74-88 (2013).
44. Mendel, J. L. & Walton, M. S. Conversion of p, p' -DDT to p, p' -DDD by intestinal flora of the rat. Science 151, 1527-1528 (1966).
45. Yim, Y.-J., Seo, J., Kang, S.-I., Ahn, J.-H. & Hur, H.-G. Reductive dechlorination of methoxychlor and DDT by human intestinal bacterium Eubacterium limosum under anaerobic conditions. Arch. Environ. Contam. Toxicol. 54, 406-411 (2008).
46. Dearfield, K. L. et al. A survey of EPA/OPP and open literature on selected pesticide chemicals. II. Mutagenicity and carcinogenicity of selected chloroacetanilides and related compounds. Mutat. Res. 443, 183-221 (1999).
47. Bakke, J. E., Gustafsson, J. A. & Gustafsson, B. E. Metabolism of propachlor by the germfree rat. Science 210, 433-435 (1980).
48. Gustafsson, J. A., Rafter, J. J., Bakke, J. E. & Gustafsson, B. E. The effect of intestinal microflora on the enterohepatic circulation of mercapturic acid pathway metabolites. Nutr. Cancer 2, 224-231 (1981).
49. Dierickx, P. J. Glutathione-dependent cytotoxicity of the chloroacetanilide herbicides alachlor, metolachlor, and propachlor in rat and human hepatomaderived cultured cells. Cell Biol. Toxicol. 15, 325-332 (1999).
50. Negri, E., Bosetti, C., Fattore, E. & La Vecchia, C. Environmental exposure to polychlorinated biphenyls (PCBs) and breast cancer: A systematic review of the epidemiological evidence. Eur. J. Cancer Prev. 12, 509-516 (2003).
51. Buck Louis, G. M. Persistent environmental pollutants and couple fecundity: An overview. Reproduction 147, R97-R104 (2014).
52. Park, H.-Y. et al. Neurodevelopmental toxicity of prenatal polychlorinated biphenyls (PCBs) by chemical structure and activity: A birth cohort study. Environ. Health 9, 51 (2010).
53. Hansen, S. et al. Maternal concentrations of persistent organochlorine pollutants and the risk of asthma in offspring: Results from a prospective cohort with 20 years of follow-up. Environ. Health Perspect. 122, 93-99 (2014).
54. Letcher, R. J., Klasson-Wehler, E. & Bergman, A. in New Types of Persistent Halogenated Compounds (ed. Paasivirta J.) 315-359 (Springer-Verlag, 2000).
55. Bakke, J. E., Bergman, A. L. & Larsen, G. L. Metabolism of 2, 4', 5-Trichlorobiphenyl by the mercapturic acid pathway. Science 217, 645-647 (1982).
56. Brandt, I., Klasson-Wehler, E., Rafter, J. & Bergman, A. Metabolism of 2, 4', 5-Trichlorobiphenyl: Tissue concentrations of methylsulphonyl-2, 4', 5-Trichlorobiphenyl in germfree and conventional mice. Toxicol. Lett. 12, 273-280 (1982).
57. Shigematsu, N. et al. Respiratory involvement in polychorinated biphenyls poisoning. Environ Res 16, 92-100 (1978).
58. Rowland, I. R. in Role of the Gut Flora in Toxicity and Cancer (ed. Rowland, I. R.) 207-226 (Academic Press, 1988).
59. Rowland, I. R., Davies, M. J. & Grasso, P. Metabolism of methylmercuric chloride by the gastro-intestinal flora of the rat. Xenobiotica 8, 37-43 (1978).
60. Nakamura, I., Hosokawa, K., Tamura, H. & Miura, T. Reduced mercury excretion with feces in germfree mice after oral administration of methyl mercury chloride. Bull. Environ. Contam. Toxicol. 17, 528-533 (1977).
61. Rowland, I. R., Davies, M. J. & Evans, J. G. Tissue content of mercury in rats given methylmercuric chloride orally: influence of intestinal flora. Arch. Environ. Health 35, 155-160 (1980).
62. Seko, Y., Miura, T., Takahashi, M. & Koyama, T. Methyl mercury decomposition in mice treated with antibiotics. Acta Pharmacol. Toxicol. (Copenh) 49, 259-265 (1981).
63. Chen, C. J., Chen, C. W., Wu, M. M. & Kuo, T. L. Cancer potential in liver, lung, bladder and kidney due to ingested inorganic arsenic in drinking water. Br. J. Cancer 66, 888-892 (1992).
64. Rowland, I. R. & Davies, M. J. In vitro metabolism of inorganic arsenic by the gastro-intestinal microflora of the rat. J. Appl. Toxicol. 1, 278-283 (1981).
65. Diaz-Bone, R. A., Hollmann, M., Wuerfel, O. Analysis of volatile arsenic compounds formed by intestinal microorganisms: Rapid identification of new metabolicproducts by use of simultaneous EI-MS and ICP-MS detection after gas chromatographic separation. J. Anal. At. Spectrom. 24: 808-814 (2009).
66. Van de Wiele, T. et al. Arsenic metabolism by human gut microbiota upon in vitro digestion of contaminated soils. Environ. Health Perspect. 118, 1004-1009 (2010).
67. Michalke, K. et al. Role of intestinal microbiota in transformation of bismuth and other metals and metalloids into volatile methyl and hydride derivatives in humans and mice. Appl. Environ. Microbiol. 74, 3069-3075 (2008).
68. Beauchamp, R. O., Irons, R. D., Rickert, D. E., Couch, D. B. & Hamm, T. E. A critical review of the literature on nitrobenzene toxicity. Crit. Rev. Toxicol. 11, 33-84 (1982).
69. Reddy, B. G., Pohl, L. R. & Krishna, G. The requirement of the gut flora in nitrobenzene-induced methemoglobinemia in rats. Biochem. Pharmacol. 25, 1119-1122 (1976).
70. Levin, A. A. & Dent, J. G. Comparison of the metabolism of nitrobenzene by hepatic microsomes and cecal microflora from Fischer-344 rats in vitro and the relative importance of each in vivo. Drug Metab. Dispos. 10, 450-454 (1982).
71. Philbert, M. A., Gray, A. J. & Connors, T. A. Preliminary investigations into the involvement of the intestinal microflora in CNS toxicity induced by 1, 3-dinitrobenzene in male F-344 rats. Toxicol. Lett. 38, 307-314 (1987).
72. Feng, J., Cerniglia, C. E. & Chen, H. Toxicological significance of azo dye metabolism by human intestinal microbiota. Front. Biosci. (Elite Ed) 4, 568-586 (2012).
73. Xu, H., Heinze, T. M., Paine, D. D., Cerniglia, C. E. & Chen, H. Sudan azo dyes and Para Red degradation by prevalent bacteria of the human gastrointestinal tract. Anaerobe 16, 114-119 (2010).
74. Macholz, R., Kujawa, M., Schulze, J., Lewerenz, H. J. & Schnaak, W. The metabolism of some xenobiotics in germ-free and conventional rats. Arch. Toxicol. Suppl. 8, 373-376 (1985).
75. Zheng, X. et al. Melamine-induced renal toxicity is mediated by the gut microbiota. Sci. Transl. Med. 5, 172ra22-172ra22 (2013).
76. Tordoff, M. G. & Alleva, A. M. Effect of drinking soda sweetened with aspartame or high-fructose corn syrup on food intake and body weight. Am. J. Clin. Nutr. 51, 963-969 (1990).
77. Nettleton, J. A. et al. Diet soda intake and risk of incident metabolic syndrome and type 2 diabetes in the Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes Care 32, 688-694 (2009).
78. Price, J. M. et al. Bladder tumors in rats fed cyclohexylamine or high doses of a mixture of cyclamate and saccharin. Science 167, 1131-1132 (1970).
79. Renwick, A. G. & Williams, R. T. The fate of cyclamate in man and other species. Biochem. J. 129, 869-879 (1972).
80. Renwick, A. G. & Williams, R. T. Gut bacteria and the metabolism of cyclamate in the rat. Biochem. J. 114, 78P (1969).
81. Bickel, M. H., Burkard, B., Meier-Strasser, E. & van den Broek-Boot, M. Entero-bacterial formation of cyclohexylamine in rats ingesting cyclamate. Xenobiotica 4, 425-439 (1974).
82. Renwick, A. G. The metabolism of intense sweeteners. Xenobiotica 16, 1057-1071 (1986).
83. Claus, S. P. & Swann, J. R. Nutrimetabonomics:applications for nutritional sciences, with specific reference to gut microbial interactions. Annu. Rev. Food Sci. Technol. 4, 381-399 (2013).
84. Rodríguez, J. M. et al. The composition of the gut microbiota throughout life, with an emphasis on early life. Microb. Ecol. Health Dis. 26, 26050 (2015).
85. Bäckhed, F. et al. Defining a healthy human gut microbiome: current concepts, future directions, and clinical applications. Cell Host Microbe 12, 611-622 (2012).
86. Russell, S. L. & Finlay, B. B. The impact of gut microbes in allergic diseases. Curr. Opin. Gastroenterol. 28, 563-569 (2012).
87. Gascon, M., Morales, E., Sunyer, J. & Vrijheid, M. Effects of persistent organic pollutants on the developing respiratory and immune systems: A systematic review. Environ. Int. 52, 51-65 (2013).
88. Menard, S. et al. Food intolerance at adulthood after perinatal exposure to the endocrine disruptor bisphenol A. FASEB J. 28, 4893-4900 (2014).
89. Maurice, C. F., Haiser, H. J. & Turnbaugh, P. J. Xenobiotics shape the physiology and gene expression of the active human gut microbiome. Cell 152, 39-50 (2013).
90. Krüger, M., Shehata, A. A., Schrödl, W. & Rodloff, A. Glyphosate suppresses the antagonistic effect of Enterococcus spp. on Clostridium botulinum. Anaerobe 20, 74-78 (2013).
91. Shehata, A. A., Schrödl, W., Aldin, A. A., Hafez, H. M. & Krüger, M. The effect of glyphosate on potential pathogens and beneficial members of poultry microbiota in vitro. Curr. Microbiol. 66, 350-358 (2013).
92. Joly, C. et al. Impact of chronic exposure to low doses of chlorpyrifos on the intestinal microbiota in the Simulator of the Human Intestinal Microbial Ecosystem (SHIME) and in the rat. Environ. Sci. Pollut. Res. Int. 20, 2726-2734 (2013).
93. Fazeli, M., Hassanzadeh, P. & Alaei, S. Cadmium chloride exhibits a profound toxic effect on bacterial microflora of the mice gastrointestinal tract. Hum. Exp. Toxicol. 30, 152-159 (2011).
94. Breton, J. et al. Ecotoxicology inside the gut: impact of heavy metals on the mouse microbiome. BMC Pharmacol. Toxicol. 14, 62 (2013).
95. Lepage, P. et al. Twin study indicates loss of interaction between microbiota and mucosa of patients with ulcerative colitis. Gastroenterology 141, 227-236 (2011).
96. Lu, K. et al. Arsenic exposure perturbs the gut microbiome and its metabolic profile in mice: An integrated metagenomics and metabolomics analysis. Environ. Health Perspect. 122, 284-291 (2014).
97. Zhang, L. et al. Persistent organic pollutants modify gut microbiota-host metabolic homeostasis in mice through aryl hydrocarbon receptor activation. Environ. Health Perspect. 123, 679-688 (2015).
98. Drasar, B. S., Renwick, A. G. & Williams, R. T. The role of the gut flora in the metabolism of cyclamate. Biochem. J. 129, 881-890 (1972).
99. Mallett, A. K., Rowland, I. R., Bearne, C. A., Purchase, R. & Gangolli, S. D. Metabolic adaptation of rat faecal microflora to cyclamate in vitro. Food Chem. Toxicol. 23, 1029-1034 (1985).
100. Rymon Lipinski Von, G.-W. The new intense sweetener acesulfame K. Food Chem. 16, 259-269 (1985).
101. Abou-Donia, M. B., El-Masry, E. M., Abdel-Rahman, A. A., McLendon, R. E. & Schiffman, S. S. Splenda alters gut microflora and increases intestinal p-glycoprotein and cytochrome p-450 in male rats. J. Toxicol. Environ. Health A 71, 1415-1429 (2008).
102. Palmnäs, M. S. A. et al. Low-dose aspartame consumption differentially affects gut microbiota-host metabolic interactions in the diet-induced obese rat. PLoS ONE 9, e109841 (2014).
103. Suez, J. et al. Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Nature 514, 181-186 (2014).
104. Menzie, C. A., Potocki, B. B. & Santodonato, J. Exposure to carcinogenic PAHs in the environment. Environ. Sci. Technol. 26, 1278-1284 (1992).
105. Bakke, J., Struble, C., Gustafsson, J. A. & Gustafsson, B. Catabolism of premercapturic acid pathway metabolites of naphthalene to naphthols and methylthio-containing metabolites in rats. Proc. Natl Acad. Sci. USA 82, 668-671 (1985).
106. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol. 15 (World Health Organization, 2013).
107. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol. 101 (World Health Organization, 2012).
108. ANSES opinion. Second French Total Diet Study (TDS2), Report 1. (French Agency For Food, Environmental and Occupational Health And Safety (ANSES), 2011).
109. ANSES opinion. Second French Total Diet Study (TDS2), Report 2. (French agency for food, environmental and occupational health and safety (ANSES), 2011).
110. Choi, J. J. et al. Exercise attenuates pcb-induced changes in the mouse gut microbiome. Environ. Health Perspect. 121, 725-730 (2013).
111. Xu, H., Heinze, T. M., Chen, S., Cerniglia, C. E. & Chen, H. Anaerobic metabolism of 1-Amino-2-naphthol-based azo dyes (Sudan dyes) by human intestinal microflora. Appl. Environ. Microbiol. 73, 7759-7762 (2007).